| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-01-31 |
|---|---|---|---|
| Revenue (Total Sales) | $738.2M | $593.4M | $471.8M |
| YoY Revenue Growth % | +24.4% | +25.8% | — |
| Gross Profit | $495.7M | $410.2M | — |
| Gross Margin % | 67.1% | 69.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$144.8M | -$122.2M | -$144.7M |
| Operating Margin % | -19.6% | -20.6% | -30.7% |
| Net Income (GAAP) | -$131.3M | -$103.7M | -$129.2M |
| EBITDA (Normalized) | -$137.1M | -$111.6M | -$127.7M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $71.4M | $36.7M | $6.8M |
| Capital Expenditures (CapEx) | $9.6M | $13.2M | $21.2M |
| Free Cash Flow (FCF) | $61.9M | $23.4M | -$14.4M |
| FCF Margin % | 8.4% | 4.0% | -3.0% |
| Return on Invested Capital (ROIC %) | -15.9% | -16.9% | -6.6% |
| Cash & Short-Term Equivalents | $124.3M | $83.1M | — |
| Total Debt (Short + Long Term) | $220.3M | $178.3M | $669.5M |
| Total Stockholders' Equity | $623.8M | $474.9M | $1.37B |